Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients (SECOX)
This study has been withdrawn prior to enrollment.
First Posted: November 22, 2010
Last Update Posted: November 9, 2011
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||August 2015|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|